ketanserin has been researched along with Psychotic Disorders in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laruelle, M | 1 |
| Abi-Dargham, A | 1 |
| Casanova, MF | 1 |
| Toti, R | 1 |
| Weinberger, DR | 1 |
| Kleinman, JE | 1 |
1 other study available for ketanserin and Psychotic Disorders
| Article | Year |
|---|---|
Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study.
Topics: Adult; Diagnosis, Differential; Down-Regulation; Female; Frontal Lobe; Humans; Ketanserin; Male; Mid | 1993 |